Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Corebridge Financial CIO David Ditillo sold 4,250 shares on July 6, 2026, at $30.00 per share, totaling $127,500. The transaction was reported on July 7, 2026, via a Form 4 filing with the SEC. Post-transaction, Ditillo holds 128,153 shares, including 40,342 restricted stock units. Corebridge Financial's stock has risen to $30.60, reflecting a 7.6%…
Dolphin Entertainment, Inc. (NASDAQ:DLPN) Chief Executive Officer William O’Dowd IV recently executed a stock purchase totaling $4,983, acquiring 4,300 shares on July 6, 2026. This transaction occurs against a backdrop of a 26% year-to-date decline in the stock's price and recent financial reports showing revenue growth alongside persistent operati…
Martin C Bicknell, recognized as a ten percent owner of Palmer Square Capital BDC Inc., has executed a series of purchases totaling approximately $647,337 in the company's common stock. The transactions occurred on July 6 and July 7, 2026, and were facilitated indirectly through MCHC, LLC. This acquisition activity takes place against a backdrop of…
Kevin J. Knopp, President and CEO of 908 Devices Inc. (NASDAQ:MASS), executed a sale of company stock totaling $2,013 on July 2, 2026. The transaction involved 222 shares sold at prices between $9.062 and $9.07 per share under a Rule 10b5-1 trading plan adopted in May 2025. This sale occurs as the stock has experienced significant gains, trading ne…
Sharon Townson, Chief Scientific Officer at Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE), executed a series of stock sales totaling approximately $139,849 on July 6, 2026. The transaction involved the liquidation of 6,000 shares of common stock, which were sold following the exercise of fully vested stock options. This insider activity occurs agains…
Anthony Meeker, a director at Barrett Business Services Inc. (NASDAQ:BBSI), executed a sale of 12,000 shares on July 2, 2026, totaling approximately $454,226. The transaction occurred as the company navigates reported macroeconomic challenges and recent financial disclosures. Meeker retains a direct stake of 44,945 shares following the divestment. …
Jennifer Fitzpatrick, Sionna Therapeutics' Chief Legal Officer, executed a sale of 10,250 shares on July 6, 2026, utilizing a Rule 10b5-1 trading plan established in June 2025. The transaction, valued at $446,862, occurred while the company's stock trades near its 52-week high, amid a period of heightened analyst scrutiny regarding its cystic fibro…
HRT Financial LP, a significant ten percent stakeholder in Edible Garden AG Inc. (NASDAQ: EDBL), has expanded its direct ownership through a series of strategic acquisitions totaling $63,435. These purchases, executed in early July 2026, occurred while the stock was trading near its 52-week low of $0.10, following a notable 39% decline over the pre…
Michael Henry Fiore, Executive Vice President and Chief Commercial Officer at HealthEquity, Inc. (NASDAQ: HQY), has executed a sale of 2,470 shares of the company’s common stock. The transaction, valued at $234,650, was conducted at a price of $95.0 per share on July 2, 2026. This sale was carried out under a Rule 10b5-1 trading plan established by…
Jenny C. Yeh, Senior Vice President and Chief Legal Officer at Ooma Inc. (NASDAQ: OOMA), executed a sale of 12,840 shares on July 1, 2026, totaling approximately $251,298. The transaction occurred as Ooma's stock trades near its 52-week high of $21.96, following a significant 70% price increase over the previous six months. The sale was reported vi…
Datadog, Inc. (NASDAQ: DDOG) Director Amit Agarwal executed a significant divestment of 19,900 Class A Common Stock shares on July 2, 2026, realizing approximately $5.22 million in proceeds. The transaction was facilitated through the Agarwal 2018 Family Trust and adhered to a pre-arranged 10b5-1 trading plan established on March 13, 2026. This sal…
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) director Rogerio Vivaldi Coelho sold 3,000 shares of the company's common stock on July 2, 2026, in a transaction valued at $120,000. The shares were sold at $40.00 each and were executed through open market transactions under a Rule 10b5-1 trading plan adopted on December 11, 2025. Following the sale, …
Yvonne Hui, Principal Accounting Officer at Phreesia, Inc. (NASDAQ:PHR), executed a sale of 1,371 shares of the company's common stock on July 6, 2026, totaling $14,861. The transaction, priced at $10.84 per share, was conducted under a Rule 10b5-1 trading plan established on January 15, 2026. Post-transaction, Hui retains direct ownership of 23,90…
Andrew Dakos, President and CEO of Total Return Securities Fund, has increased his ownership stake following a recent share acquisition. The transaction occurred as the stock traded near its 52-week low, with the fund maintaining profitability and a low price-to-earnings ratio. This insider activity provides insight into executive sentiment regardi…
HRT Financial LP, a notable ten percent shareholder in Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH), executed recent transactions involving the company's common stock. The firm sold 9,022 shares on July 6, 2026, at $3.51 per share, while previously acquiring 7,851 shares on July 2, 2026, at $3.54 per share. These activities follow Shuttle P…
Rudy Mitchell Austin, a director and significant 10% shareholder of BONK, INC. (NASDAQ:BNKK), has increased his indirect ownership in the company. The acquisition, executed through Nom Capital ULC, brings his total holdings to 85,000 shares. This move occurs against a backdrop of significant stock price depreciation over the past year and recent re…
Jill Foss Watson, a principal 10% owner of Credit Acceptance Corp (NASDAQ:CACC), executed a significant sale of 11,100 shares on July 2, 2026. The transactions, valued at approximately $7.19 million, occurred as the stock trades near its 52-week peak. The sale was facilitated through two distinct trust structures, leaving Watson with substantial in…
Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, Inc., executed a series of transactions involving the company’s Class A Common Stock on July 6, 2026. The CFO exercised stock options and subsequently sold 7,163 shares through a Rule 10b5-1 trading plan established on May 21, 2025. The sale, valued at approximately $261,351, occurred at…
Aidan Viggiano, Chief Financial Officer at Twilio Inc. (NASDAQ: TWLO), sold 8,528 shares of the company’s Class A common stock for $1,751,907 on July 2, 2026, according to a filing with the Securities and Exchange Commission. The sale was conducted under a pre-arranged 10b5-1 trading plan established on June 6, 2025. Following the transaction, Vigg…
Eastern Bankshares, Inc. (NASDAQ:EBC) director Luis Borgen sold 1,710 shares of common stock on July 6, 2026, for a total of $38,834. The transaction, executed under a 10b5-1 plan, took place as the stock traded near its 52-week high of $22.89. Following the sale, Borgen retains a direct stake of 20,475 shares, comprising common and restricted stoc…
Jayabalan Harish, Executive Vice President, Chief Information Security Officer, and Chief Risk Officer at Miami International Holdings, Inc. (NASDAQ: MIAX), executed a series of stock transactions on July 6, 2026. The executive sold 20,000 shares valued at $842,400 while simultaneously acquiring 20,000 shares through the exercise of nonqualified st…
HRT Financial LP, a significant shareholder in Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR), executed recent purchases of the company's common stock totaling $25,880. The acquisitions span a wide price range from $0.0814 to $1.39 per share, taking place against a backdrop of severe stock depreciation and active corporate restructuring.…
John Uczekaj, President and Chief Operating Officer of AIRO Group Holdings, Inc. (NASDAQ: AIRO), executed a transaction on July 6, 2026, selling 154 shares of common stock. The sale, valued at $1,195, was conducted to satisfy tax withholding obligations linked to the vesting of restricted stock units. Following this divestment, Uczekaj's direct own…
Ourania Tatsis, Executive Vice President and Chief Regulatory & Quality Officer at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), executed a sale of company stock totaling $787,485 on July 2, 2026. The transaction involved the disposition of 1,500 shares at $524.99 per share, leaving her with a direct holding of 45,321 shares. The sale was conducted un…
Butterfly Network, Inc. (NASDAQ: BFLY) reported a recent transaction involving its Chief Accounting Officer and Senior Vice President of Finance, Megan Carlson, who sold 41,303 shares of Class A Common Stock on July 2, 2026. The transaction, totaling $328,937, was executed under a sell-to-cover policy to meet tax withholding requirements associated…
